Worthy of re-post TXTM Significant Research to Consider…
Below are some TXTM posts that I made a while back that might help one to understand the magnitude of the company upon the Marijuana License approval for the country of South Africa and much more:
Comprehensive $TXTM DD package Sterling, well done. Thank you for taking the time to retrieve and compile this important DD.
What I've understood after listening to last week's Parliament hearing, is that South Africa has gone through much of the due process, and is consequently now positioned to reschedule/down-schedule cannabis within the next few weeks.
Upon the SA governmental ratification, according to the founder of SACCRA Jason Sean O'Donoghue, Plandai SA/Protext Pharma is expected to "gain access" to a research and development license that will allow for the company to employ its proprietary technology to produce a pharmaceutical grade non-psychoactive cannabis product under license from America. IMO, the implications of South Africa down-scheduling cannabis are profound for $TXTM. It will be interesting to see what unfolds over the next few weeks.
You let out myriad reasons to get excited about the prospects here with $TXTM. It sure looks like plenty of loading from .0005-.0008 pps going on last 7 sessions.
I think you highlight very intriguing reasons in your well thought out due diligence and this sure does look like the bottom here.